Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 23,498 shares at $8.57 ($201K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Open-market sale of $201k ADPT by Chief Commercial Ofc Imm Med. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.57 | 11,749 | $101K | 50.0% |
| 2 | $8.57 | 11,749 | $101K | 50.0% |
| Total | $8.57 avg | 23,498 | $201K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |